1516 related articles for article (PubMed ID: 20920745)
1. Histone modifications and cancer.
Sawan C; Herceg Z
Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic information in chromatin and cancer.
Herceg Z
Eur J Cancer; 2009 Sep; 45 Suppl 1():442-4. PubMed ID: 19775664
[TBL] [Abstract][Full Text] [Related]
3. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
4. Histone onco-modifications.
Füllgrabe J; Kavanagh E; Joseph B
Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
[TBL] [Abstract][Full Text] [Related]
5. DNA methylomes, histone codes and miRNAs: tying it all together.
Guil S; Esteller M
Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952
[TBL] [Abstract][Full Text] [Related]
6. Setting and resetting of epigenetic marks in malignant transformation and development.
Richly H; Lange M; Simboeck E; Di Croce L
Bioessays; 2010 Aug; 32(8):669-79. PubMed ID: 20658705
[TBL] [Abstract][Full Text] [Related]
7. Histone H2A ubiquitination in transcriptional regulation and DNA damage repair.
Zhou W; Wang X; Rosenfeld MG
Int J Biochem Cell Biol; 2009 Jan; 41(1):12-5. PubMed ID: 18929679
[TBL] [Abstract][Full Text] [Related]
8. Chromatin modifier enzymes, the histone code and cancer.
Santos-Rosa H; Caldas C
Eur J Cancer; 2005 Nov; 41(16):2381-402. PubMed ID: 16226460
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic control of ovarian function: the emerging role of histone modifications.
LaVoie HA
Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of epigenetic inheritance.
Martin C; Zhang Y
Curr Opin Cell Biol; 2007 Jun; 19(3):266-72. PubMed ID: 17466502
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
12. Chromatin remodeling and cancer, Part I: Covalent histone modifications.
Wang GG; Allis CD; Chi P
Trends Mol Med; 2007 Sep; 13(9):363-72. PubMed ID: 17822958
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
14. Histone acetylation and chromatin signature in stem cell identity and cancer.
Shukla V; Vaissière T; Herceg Z
Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
[TBL] [Abstract][Full Text] [Related]
15. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
Geiman TM; Robertson KD
J Cell Biochem; 2002; 87(2):117-25. PubMed ID: 12244565
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
Bhalla KN
J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
[TBL] [Abstract][Full Text] [Related]
17. Replication stress, a source of epigenetic aberrations in cancer?
Jasencakova Z; Groth A
Bioessays; 2010 Oct; 32(10):847-55. PubMed ID: 20726011
[TBL] [Abstract][Full Text] [Related]
18. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
An W
Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
[TBL] [Abstract][Full Text] [Related]
19. Orchestration of chromatin-based processes: mind the TRRAP.
Murr R; Vaissière T; Sawan C; Shukla V; Herceg Z
Oncogene; 2007 Aug; 26(37):5358-72. PubMed ID: 17694078
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic markers and their cross-talk.
Winter S; Fischle W
Essays Biochem; 2010 Sep; 48(1):45-61. PubMed ID: 20822485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
